INTERNATIONAL PATENT: IMMORTA BIO, INC. FILES APPLICATION FOR "TREATMENT OF LIVER FAILURE USING PERSONALIZED PROGENITOR CELLS AND DERIVATIVES THEREOF"

GENEVA, June 12 -- IMMORTA BIO, INC. (7064 Fisher Island DriveMiami Beach, Florida 33109) filed a patent application (PCT/US2024/057338) for "TREATMENT OF LIVER FAILURE USING PERSONALIZED PROGENITOR CELLS AND DERIVATIVES THEREOF" on Nov 25, 2024. With publication no. WO/2025/117474, the details related to the patent application was published on Jun 05, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): ICHIM, Thomas E. (c/o IMMORTA BIO, INC.7064 Fisher Island DriveMiami Beach, Florida 33109), REZNIK, Boris (c/o Immorta Bio, Inc.7064 Fisher Island DriveMiami Beach, Florida 33109), REZNIK, Gary (...